Squarepoint
OTLK icon

Squarepoint’s Outlook Therapeutics OTLK Stock Holding History

Squarepoint’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,699
Closed -$18.5K – 4773
2025
Q4 		$18.5K Buy
+11,699
New +$18.7K ﹤0.01% 4173
2025
Q3 		– Sell
-155,624
Closed -$249K – 4812
2025
Q2 		$249K Buy
+155,624
New +$248K ﹤0.01% 3823
2024
Q3 		– Sell
-31,388
Closed -$232K – 4542
2024
Q2 		$232K Buy
+31,388
New +$252K ﹤0.01% 3575
2023
Q3 		– Sell
-15,829
Closed -$551K – 4115
2023
Q2 		$551K Buy
15,829
+12,572
+386% +$343K ﹤0.01% 2567
2023
Q1 		$71K Buy
+3,257
New +$72.9K ﹤0.01% 3022
2022
Q4 		– Sell
-1,605
Closed -$39K – 3503
2022
Q3 		$39K Buy
+1,605
New +$37.3K ﹤0.01% 2877
2022
Q2 		– Sell
-1,597
Closed -$57K – 3239
2022
Q1 		$57K Buy
+1,597
New +$49.9K ﹤0.01% 2670
2021
Q4 		– Sell
-565
Closed -$25K – 3436
2021
Q3 		$25K Buy
565
+5
+0.9% +$241 ﹤0.01% 2816
2021
Q2 		$28K Sell
560
-334
-37% -$15.5K ﹤0.01% 3136
2021
Q1 		$40K Buy
+894
New +$34.2K ﹤0.01% 2999
2020
Q3 		– Sell
-810
Closed -$21K – 2745
2020
Q2 		$21K Buy
+810
New +$14.4K ﹤0.01% 2153
2019
Q3 		– Sell
-1,385
Closed -$58K – 2592
2019
Q2 		$58K Buy
+1,385
New +$64.5K ﹤0.01% 2272

Other funds holding OTLK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $126M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return

Squarepoint's OTLK Position: Q1 2026 in Review

Squarepoint sold out of Outlook Therapeutics (OTLK) in Q1 2026, closing a stake of 11,699 shares — an estimated $18.5K sold.

Squarepoint first reported a position in OTLK in Q2 2019 and held it in 12 quarters. The position peaked at $551K in Q2 2023. 54 funds tracked by Wall St. Rank hold OTLK as of Q1 2026.

  • Squarepoint reported no remaining Outlook Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Squarepoint sold 11,699 Outlook Therapeutics shares in Q1 2026, an estimated $18.5K.
  • Squarepoint first reported a position in Outlook Therapeutics in Q2 2019 and held it in 12 quarters.
  • Squarepoint's Outlook Therapeutics position peaked at $551K in Q2 2023.
  • 54 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.